Drug interaction in breast cancer patients: an integrative review
DOI:
https://doi.org/10.33448/rsd-v10i16.21243Keywords:
Drug interactions; Breast cancer; Brazil.Abstract
Breast cancer is a disease caused by the disordered multiplication of breast cells. This process generates abnormal cells that multiply, forming a tumor. An integrative literature review was carried out with the aim of characterizing the research produced with the theme drug interaction in patients with breast cancer. The bibliographic survey covered studies carried out in Brazil, with no restrictions on the year of publication of the works, in scientific journals and that were adequate to the theme proposed for the work, in the period from August to September 2021 in the PubMed, SCIELO and VHL, using the following descriptors: “Drug Interactions”, “breast cancer” and “Brazil”. After analysis, 9 articles were identified that made up the study sample. The results show that in most of the articles analyzed, drug interaction in cancer patients is presented as the main problem related to drugs. In all, the importance of monitoring prescriptions and working together with the multidisciplinary team is perceived, with the pharmacist being fundamental for the care of patients with breast cancer.
References
Amaral, P. A., Mendonça, S. M., Oliveira, D. R., Peloso, L.J., Pedroso, R. S., & Ribeiro, M. A. (2018). Impact of a medication therapy management service offered to patients in treatment of breast câncer. Brazilian Journal of Pharmaceutical Science: 1-12. http://dx.doi.org/10.1590/s2175-97902018000200221.
Aguiar, R. B., Leal, M. C.C., Marques, A. P. de O., Torres, K. M. S., & Tavares, M. T. D. B. (2020) Idosos vivendo com HIV – comportamento e conhecimento sobre sexualidade: revisão integrativa. Ciência & Saúde Coletiva: 575-584. https://doi.org/10.1590/1413-81232020252.12052018.
Antunes, M.V., Timm, T. A. F., De Oliveira, V., Staudt, D. E., Raymundo, S., Gössling, G., Biazús, J.V., Cavalheiro, J. A., Rosa, D. D., Wallemacq, P., Haufroid, V., Linden, R., & Schwartsmann, G. (2015). Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation. Ther Drug Monit:733-744. https://pubmed.ncbi.nlm.nih.gov/25853922/.
Batista, A.V.A., Dos Santos, V. R. C., & Carneiro, I. C. R. S. (2021). Cuidado farmacêutico em oncologia: Revisão integrativa da literatura. Research, Society and Development:1-14. https://rsdjournal.org/index.php/rsd/article/download/14987/13497/195839.
Cupertino, A., Marcondes, M. A., & Gatti, R. M. (2008). Estudo retrospectivo das reações adversas e interações medicamentosas na quimioterapia no tratamento do câncer de mama: relato de caso. Revista Brasileira de Ciências da Saúde: 26-36. https://seer.uscs.edu.br/index.php/revista_ciencias_saude/article/view/356.
Domínguez-Alonso, J.A., Conde-Estévez, D., Bosch, D. Pi-Figueras, M., & Tuquets, I. (2021). Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything? Clinical and Translational Oncology: 23, 65–73 (2021). Disponível em: https://doi.org/10.1007/s12094-020-02386-8.
Faria, C. O., Reis, C. M., Santos, A. G., & Reis, A. M. M. (2018). Interações Medicamentosas na Farmacoterapia de Idosos com Câncer atendidos em um Ambulatório de Onco-Hematologia. Revista Brasileira de Cancerologia: 61-68. https://rbc.inca.gov.br/revista/index.php/revista/article/view/119.
Ferracini, A. C., Rodrigues, A. T., De Barros, A. A., Derchain, S. F., & Mazzola, P. G. (2017). Prescribing errors intercepted by pharmacist intervention in care of patients hospitalised with breast and gynaecological cancer at a Brazilian teaching hospital. European Journal Cancer Care:1-7. https://pubmed.ncbi.nlm.nih.gov/28925569/.
Garcia, H. O. Efeito da interação medicamentosa entre tamoxifeno e antidepressivos inibidores da cyp2d6 na morbimortalidade de mulheres com câncer de mama: uma revisão sistemática. Porto Alegre. 2021. Trabalho de Conclusão de Curso (Faculdade de Farmácia), Universidade Federal do Rio Grande do Sul. Porto Alegre, 2021. http://hdl.handle.net/10183/225671.
Instituto Nacional do Câncer (INCA/MS). Tipos de câncer: Câncer de mama. 2020. Disponível em: https://www.inca.gov.br/estimativa/sintese-deresultados-e-comentários.
Irarrázaval, M. E., & Gaete, L. (2016). Elección del mejor antidepresivo en pacientes con cáncer de mama en tratamiento con tamoxifeno: revisión de la evidencia básica y clínica. Revista Médica de Chile:1326– 1335. https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016001000013&lng=en&nrm=iso&tlng=en.
Lima, B. A., Costa, C. L., Cavalcante, K. A. F., Pereira, S. M., Brito, M. A. M., & Jimenez, K. L. (2021). Desenvolvimento de protocolo de acompanhamento farmacoterapêutico a pacientes em tratamento de câncer de mama. Brazilian Journal of Health Review: 11321-11340. https://www.brazilianjournals.com/index.php/BJHR/article/view/30258.
Lobo, R. E. D., Bahia, B. P. G., Silva, G. E. A., Cruz, L. N., Sarges, E. S., Lo Prete, A. C., Carneiro, T. X., & Ribeiro, C. H. M. A. (2021) Interação medicamentosa em pacientes com câncer: revisão integrativa da literatura. Brazilian Journal of Development: 32289-32303. https://www.brazilianjournals.com/index.php/BRJD/article/view/27304.
Machado, M. X., Soares, D. A., & Oliveira, S. B. (2017). Significados do câncer de mama para mulheres no contexto do tratamento quimioterápico. Physis Revista de Saúde Coletiva: 433-451. https://doi.org/10.1590/S0103-73312017000300004.
Moriel, P., Siqueira, J. A., Carnevale, R. C., Costa, C. G. R., Da Cruz, A. A., Da Silva, N. M. O., Bernardes, A. C., Carvalho, R. P., & Mazzola, P. G. (2013). Drug interactions in female oncologic inpatients: differences among databases. Revista de Ciências Farmacêuticas Básica e Aplicada: 333-337. https://rcfba.fcfar.unesp.br/index.php/ojs/article/view/193
Quemel, G. K. C., Da Silva, E. P., Conceição, W. R., Gomes, M. F., Rivera, J. G. B., & Quemel, G. K, C. (2018). Revisão integrativa da literatura sobre o aumento no consumo de psicotrópicos em transtornos mentais como a depressão. Brazilian Applied Science Review:1384-1403. https://www.brazilianjournals.com/index.php/BASR/article/view/30182
Rodrigues, H. S., Souza, R. P., Sousa, R. W. R. de, Pereira, L. C. A., Branco, R. R. de O. C., Silveira, P. H. F. P., & Britto, M. H. R. M. (2020). Drug interactions profile of Oral Antineoplastic Agents (OAAs) dispensed for oncologic patients. Research, Society and Development, 9(8), e145985369. https://doi.org/10.33448/rsd-v9i8.5369
Silva, G. G. S., Silva, J. A., Souza, E. B., Gomes, S. A. C., Santana, N. B. L., Galindo, J. A., Tenório, E. M. A., Melo, R. K. S., Souza, A. P., & Barros, Danilo, P. O. (2020). Importância do farmacêutico clínico na diminuição das interações medicamentosas ao paciente oncológico na unidade de terapia intensiva. Brazilian Journal of health Review: 3 (5) 15542-15556.
Topaloğlu, U. S., & Özaslan, E. (2020). Comorbidity and polypharmacy in patients with breast cancer. Breast Cancer: 27, 477–482. https://doi.org/10.1007/s12282-019-01040-8
Yamagata, A. T., Coelho, R. M. P., Júnior, B., Galato, D., Meiners, M. M. M. A., & Da Silva, E. V. (2018). Perfil dos estudos de interações medicamentosas potenciais em hospitais brasileiros: revisão integrativa. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde: 1-9. https://www.rbfhss.org.br/sbrafh/article/download/386/375
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Simone Cristina Pinheiro da Costa; Ana Cristina Lo Prete; Carolina Heitmann Mares Azevedo Ribeiro
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
